315 related articles for article (PubMed ID: 32588088)
21. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [
Zhang X; Chen L; Jiang H; He X; Feng L; Ni M; Ma M; Wang J; Zhang T; Wu S; Zhou R; Jin C; Zhang K; Qian W; Chen Z; Zhuo C; Zhang H; Tian M
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1298-1310. PubMed ID: 34651227
[TBL] [Abstract][Full Text] [Related]
22. Use of radiomics based on
Zhou Y; Ma XL; Zhang T; Wang J; Zhang T; Tian R
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2904-2913. PubMed ID: 33547553
[TBL] [Abstract][Full Text] [Related]
23. Pretreatment
Dissaux G; Visvikis D; Da-Ano R; Pradier O; Chajon E; Barillot I; Duvergé L; Masson I; Abgral R; Santiago Ribeiro MJ; Devillers A; Pallardy A; Fleury V; Mahé MA; De Crevoisier R; Hatt M; Schick U
J Nucl Med; 2020 Jun; 61(6):814-820. PubMed ID: 31732678
[TBL] [Abstract][Full Text] [Related]
24. Combination of
Li S; Li Y; Zhao M; Wang P; Xin J
Korean J Radiol; 2022 Sep; 23(9):921-930. PubMed ID: 36047542
[TBL] [Abstract][Full Text] [Related]
25. Machine learning approach using 18 F-FDG PET-based radiomics in differentiation of lung adenocarcinoma with bronchoalveolar distribution and infection.
Agüloğlu N; Aksu A; Unat DS
Nucl Med Commun; 2023 Apr; 44(4):302-308. PubMed ID: 36756766
[TBL] [Abstract][Full Text] [Related]
26. Identifying pathological subtypes of non-small-cell lung cancer by using the radiomic features of
Sha X; Gong G; Qiu Q; Duan J; Li D; Yin Y
Transl Cancer Res; 2019 Sep; 8(5):1741-1749. PubMed ID: 35116924
[TBL] [Abstract][Full Text] [Related]
27. Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT.
Brown PJ; Zhong J; Frood R; Currie S; Gilbert A; Appelt AL; Sebag-Montefiore D; Scarsbrook A
Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2790-2799. PubMed ID: 31482428
[TBL] [Abstract][Full Text] [Related]
28. Ability of
Ou X; Wang J; Zhou R; Zhu S; Pang F; Zhou Y; Tian R; Ma X
Contrast Media Mol Imaging; 2019; 2019():4507694. PubMed ID: 30930700
[No Abstract] [Full Text] [Related]
29. Predictive value of radiomic signature based on 2-[
Liu J; Zhang Z; Bian H; Zhang Y; Ma W; Wang Z; Yin G; Dai D; Chen W; Zhu L; Xu W; Zhang H; Li X
Eur J Radiol; 2023 Oct; 167():111050. PubMed ID: 37598640
[TBL] [Abstract][Full Text] [Related]
30. Development and Validation of a
Ouyang ML; Wang YR; Deng QS; Zhu YF; Zhao ZH; Wang L; Wang LX; Tang K
Front Oncol; 2021; 11():710909. PubMed ID: 34568038
[TBL] [Abstract][Full Text] [Related]
31. Radiomics nomogram for preoperative differentiation of pulmonary mucinous adenocarcinoma from tuberculoma in solitary pulmonary solid nodules.
Zhang J; Hao L; Qi M; Xu Q; Zhang N; Feng H; Shi G
BMC Cancer; 2023 Mar; 23(1):261. PubMed ID: 36944978
[TBL] [Abstract][Full Text] [Related]
32. Machine learning for differentiating lung squamous cell cancer from adenocarcinoma using Clinical-Metabolic characteristics and 18F-FDG PET/CT radiomics.
Zhang Y; Liu H; Chang C; Yin Y; Wang R
PLoS One; 2024; 19(4):e0300170. PubMed ID: 38568892
[TBL] [Abstract][Full Text] [Related]
33. Prediction of EGFR mutation status in lung adenocarcinoma based on
Tan JL; Xia L; Sun SG; Zeng H; Lu DY; Cheng XJ
Am J Nucl Med Mol Imaging; 2023; 13(5):230-244. PubMed ID: 38023818
[TBL] [Abstract][Full Text] [Related]
34. The Usefulness of Machine Learning-Based Evaluation of Clinical and Pretreatment [
Nakajo M; Kawaji K; Nagano H; Jinguji M; Mukai A; Kawabata H; Tani A; Hirahara D; Yamashita M; Yoshiura T
Mol Imaging Biol; 2023 Apr; 25(2):303-313. PubMed ID: 35864282
[TBL] [Abstract][Full Text] [Related]
35. Applications of radiomics-based analysis pipeline for predicting epidermal growth factor receptor mutation status.
Liu Z; Zhang T; Lin L; Long F; Guo H; Han L
Biomed Eng Online; 2023 Feb; 22(1):17. PubMed ID: 36810090
[TBL] [Abstract][Full Text] [Related]
36. Pre-operative Prediction of Ki-67 Expression in Various Histological Subtypes of Lung Adenocarcinoma Based on CT Radiomic Features.
Huang Z; Lyu M; Ai Z; Chen Y; Liang Y; Xiang Z
Front Surg; 2021; 8():736737. PubMed ID: 34733879
[No Abstract] [Full Text] [Related]
37. Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma.
Nie P; Yang G; Wang N; Yan L; Miao W; Duan Y; Wang Y; Gong A; Zhao Y; Wu J; Zhang C; Wang M; Cui J; Yu M; Li D; Sun Y; Wang Y; Wang Z
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):217-230. PubMed ID: 32451603
[TBL] [Abstract][Full Text] [Related]
38. Discrimination of mediastinal metastatic lymph nodes in NSCLC based on radiomic features in different phases of CT imaging.
Sha X; Gong G; Qiu Q; Duan J; Li D; Yin Y
BMC Med Imaging; 2020 Feb; 20(1):12. PubMed ID: 32024469
[TBL] [Abstract][Full Text] [Related]
39. A comparative study for the evaluation of CT-based conventional, radiomic, combined conventional and radiomic, and delta-radiomic features, and the prediction of the invasiveness of lung adenocarcinoma manifesting as ground-glass nodules.
Lv Y; Ye J; Yin YL; Ling J; Pan XP
Clin Radiol; 2022 Oct; 77(10):e741-e748. PubMed ID: 35840455
[TBL] [Abstract][Full Text] [Related]
40. Value of
Shao X; Niu R; Shao X; Jiang Z; Wang Y
EJNMMI Res; 2020 Jul; 10(1):80. PubMed ID: 32661639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
